Business

Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial

Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.

adminadmin
Jun 21, 2024 - 02:00
 0  17
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
Read More

Tags:

Previous Article

Fast-food customers are shifting to casual-dining chains, Darden Restaurants CEO...

Next Article

Darden beats on earnings, even as Olive Garden, fine-dining sales drag

admin
admin

Related Posts

Warner Bros. Discovery and ESPN strike 5-year deal for College Football Playoff games

Warner Bros. Discovery and ESPN strike 5-year deal for ...

admin May 23, 2024  0  19

Sony and Apollo send letter expressing interest in $26 billion Paramount buyout as company mulls Skydance bid

Sony and Apollo send letter expressing interest in $26 ...

admin May 15, 2024  0  29

Starbucks taps former Chipotle executive as global chief brand officer

Starbucks taps former Chipotle executive as global chie...

admin Oct 19, 2024  0  8